R1 RCM : 2021 RBC Capital Markets Global Healthcare Conference

Investor Presentation

May 2021

Forward-Looking Statements and Non-GAAP Financial Measures

This presentation includes information that may constitute "forward-looking statements," made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future, not past, events and often address our expected future growth, plans and performance or forecasts. These forward-

looking statements are often identified by the use of words such as "anticipate," "believe," "designed," "estimate," "expect," "forecast," "intend," "may," "plan," "predict,"

"project," "target," "will," or "would," and similar expressions or variations, although not all forward-looking statements contain these identifying words. These forward-looking statements include, among other things, statements about the potential impacts of the COVID-19 pandemic, our strategic initiatives, our capital plans, our costs, our ability to successfully deliver on our commitments to our customers, our ability to deploy new business as planned, our ability to successfully implement new technologies, our future financial performance and our liquidity, the VisitPay acquisition and the anticipated benefits of acquisitions, dispositions, and other strategic transactions. Such forward-looking statements are based on management's current expectations about future events as of the date hereof and involve many risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in our forward-looking statements. Subsequent events and developments, including actual results or changes in our assumptions, may cause our views to change. We do not undertake to update our forward-looking statements except to the extent required by applicable law. You are cautioned not to place undue reliance on such forward-looking statements.

All forward-looking statements included herein are expressly qualified in their entirety by these cautionary statements. Our actual results and outcomes could differ materially from those included in these forward-looking statements as a result of various factors, including, but not limited to, our ability to retain existing customers or acquire new customers; the development of markets for our RCM service offering; the impact of the COVID-19 pandemic on our business, operating results and financial condition; our ability to close the VisitPay acquisition and integrate its business as planned; our ability to integrate our customers' revenue cycle management employees; our ability to realize the anticipated benefits of acquisitions, strategic initiatives and other investments; developments in the healthcare industry, including national healthcare reform; and the factors

discussed under the heading "Risk Factors" in our annual report on Form 10-K for the year ended December 31, 2020, our quarterly reports on Form 10-Q and any other periodic reports that R1 RCM Inc. (the "Company") files with the Securities and Exchange Commission (the "SEC").

This presentation includes the following financial measure that was not prepared in accordance with U.S. generally accepted accounting principles ("GAAP"): Adjusted EBITDA. Adjusted EBITDA may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. This non-GAAP financial measure should not be considered in isolation or as a substitute for analysis of our results of operations as reported under GAAP. Please refer to the Appendix located at the end of this presentation for a reconciliation of the non-GAAP financial measure to the most directly comparable GAAP financial measure.

2

Leading Technology-Driven Platform to Manage Healthcare Provider Revenue

Revenue Cycle	Large, Growing	Significant	Strong Visibility
Platform for	Addressable
Growth	and High Margin
Leading Providers	Market

$1.3B		$110B1		>15%				>90%
2020 Revenue		Acute & Ambulatory		Revenue CAGR, 2018-2020			Recurring Revenue
$40B+		RCM Market		>100%				~30%
NPR Under Management				Adj. EBITDA CAGR, 2018-2020		Long-Term Adj. EBITDA Margin

Note1: CMS NHE Projections and R1 estimates	3
Note: Adjusted EBITDA is a non-GAAP measure, please refer to the Appendix for a reconciliation of non-GAAP financial measures

Transforming Revenue Performance Across Care Settings and Payment Models

All Care Settings

Ambulatory

Acute

Post-Acute

All Revenue Cycle Phases

	Order to Intake	Care to Claim	Claim to Payment
Solutions address the full
spectrum of needs and	All Payment Models
operations
	Fee-for-service	Patient Self-pay	Value-based

4

Compelling Value Proposition for All Healthcare Providers

NEED

VALUE ADD

RESULTS

Growing pressure to run

revenue cycle

more efficiently

We plug into healthcare providers' existing IT systems

• Higher patient satisfaction
• Lower costs
• Higher revenue
• Faster collections

5